Conformal Therapy and Intensity-Modulated Radiation Therapy: Treatment Planning, Treatment Delivery, and Clinical Results

Clinical Radiation Oncology: Third Edition

Volumn , Issue , 2012, Pages 287-316

  Fraass, Benedick A ^a   Jolly, Shruti ^a   Eisbruch, Avraham ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84967214671     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4377-1637-5.00015-8     Document Type: Chapter

References (303)

1. Takahashi S Conformation radiotherapy. Rotation techniques as applied to radiography and radiotherapy of cancer. Acta Radiol Suppl 1965, 242:1-141.
2. Mantel J, Perry H, Weinham JJ Automatic variation of field size and dose rate in rotation therapy. Int J Radiat Oncol Biol Phys 1977, 2:697-704.
3. Proimos BS Beam-shapers oriented by gravity in rotational therapy. Radiology 1966, 87:928-932.
4. Proimos BS Shaping the dose distribution through a tumor model. Radiology 1969, 92:130-135.
5. Proimos BS Synchronous field shaping in rotational megavolt therapy. Radiology 1960, 74:753-757.
6. Trump JG, Wright KA, Smedal MI, et al. Synchronous field shaping and protection in 2-million-volt rotational therapy. Radiology 1961, 76:275.
7. Wright KA, Proimos BS, Trump JG, et al. Field shaping and selective protection in megavolt radiation therapy. Radiology 1959, 72:101.
8. Jennings WA The Tracking Cobalt Project: From moving-beam therapy to three-dimensional programmed irradiation. Progress in medical radiation physics 1985, 1-44. Plenum Press, New York. C. Orton (Ed.).
9. Green A Tracking Cobalt Project. Nature 1965, 207:1311.
10. Green A, Jennings WA, Christie HM Radiotherapy by tracking the spread of disease. Transactions of the Ninth International Congress of Radiology, Munchen 1959 1960, 766-772. Verlag, Munchen.
11. Brace JA, Davy TJ, Skeggs DBL, Williams HL Conformation therapy at the Royal Free Hospital. A progress report on the Tracking Cobalt Project. BJR 1981, 54:1068-1074.
12. Chin L, Kijewski PK, Svensson GK, et al. A computer-controlled radiation therapy machine for pelvic and paraaortic nodal areas. Int J Radiat Oncol Biol Phys 1981, 7:61-70.
13. Chin LM, Kijewski PK, Svensson GK, Bjarngard BE Dose optimization with computer-controlled gantry rotation, collimator motion and dose-rate variation. Int J Radiat Oncol Biol Phys 1983, 9:723-729.
14. Kijewski PK, Chin LM, Bjarngard BE Wedge-shaped dose distributions by computer-controlled collimator motion. Med Phys 1978, 5:426-429.
15. Levene MB, Kijewski PK, Chin LM, et al. Computer-controlled radiation therapy. Radiology 1978, 129:769-775.
16. Brizel HE, Livingston PA, Grayson EV Radiotherapeutic applications of pelvic CT. J Comput Assist Tomogr 1974, 4:453-466.
17. Goitein M, Wittenberg J, Mendiondo M, et al. The value of CT scanning in radiation therapy treatment planning. A prospective study. Int J Radiat Oncol Biol Phys 1979, 5:1787-1793.
18. Munzenrider JE, Pilepich M, Rene-Ferrero J, et al. Use of body scanner in radiotherapy treatment planning. Cancer 1977, 40:170-179.
19. Computed tomography in radiation therapy 1983, Raven Press, New York. C.C. Ling, C.C. Rogers, R.J. Morton (Eds.).
20. Cunningham JR Current and future development of tissue inhomogeneity corrections for photon beam clinical dosimetry with use of CT. Computed tomography in radiation therapy 1983, 209-218. Raven Press, New York. C.C. Ling, C.C. Rogers, R.J. Morton (Eds.).
21. Fraass BA, McShan DL, Diaz RF, et al. Integration of magnetic resonance imaging into radiation therapy treatment planning. Technical considerations. Int J Radiat Oncol Biol Phys 1987, 13:1897-1908.
22. Goitein M, Abrams M Multi-dimensional treatment planning. I. Delineation of anatomy. Int J Radiat Oncol Biol Phys 1983, 8:777-787.
23. Goitein M, Abrams M, Rowell D, et al. Multi-dimensional treatment planning. II. Beam's eye-view back projection, and projection through CT sections. Int J Radiat Oncol Biol Phys 1983, 9:780-797.
24. McShan DL, Reinstein LE, Land RE, Glicksman AS Automatic contour recognition in three-dimensional treatment planning. Computed tomography in radiation therapy 1983, 167-173. Raven Press, New York. C.C. Ling, C.C. Rogers, R.J. Morton (Eds.).
25. McShan DL, Silverman A, Lanza D, et al. A computerized three-dimensional treatment planning system utilizing interactive color graphics. BJR 1979, 52:478-481.
26. Reinstein LE, McShan DL, Land RE, Glicksman AS Three-dimensional reconstruction of CT images for treatment planning in carcinoma of the lung. Computed tomography in radiation therapy 1983, 155-165. Raven Press, New York. C.C. Ling, C.C. Rogers, R.J. Morton (Eds.).
27. McShan DL, Fraass BA, Lichter AS Full integration of the beam's eye view concept into clinical treatment planning. Int J Radiat Oncol Biol Phys 1990, 18:1485-1494.
28. Fraass BA, McShan DL 3D treatment planning. I. Overview of a clinical planning system. The use of computers in radiation therapy 1987, 273-276. Elsevier Science BV, North Holland. I.A.D. Bruinvis, F.H. van der Giessen, H.J. van Kleffens, F.W. Wittkamper (Eds.).
29. Bauer-Kirpes B, Schlegel W, Boesecke R, Lorenz WJ Display of organs and isodoses as shaded 3D objects for 3D therapy planning. Int J Radiat Oncol Biol Phys 1987, 13:130-140.
30. Mohan R, Barest G, Brewster LJ, et al. A comprehensive three-dimensional radiation treatment planning system. Int J Radiat Oncol Biol Phys 1988, 15:481-495.
31. Rosenman J, Sherouse GW, Fuchs H, et al. Three-dimensional display techniques in radiation therapy treatment planning. Int J Radiat Oncol Biol Phys 1989, 16:263-269.
32. Sherouse GW, Mosher CE, Novine K, et al. Virtual simulation. Concept and implementation. The use of computers in radiation therapy 1987, 423-436. Elsevier Science BV, North Holland. I.A.D. Bruinvis, F.H. van der Giessen, H.J. van Kleffens, F.W. Wittkamper (Eds.).
33. Brahme A Design principles and clinical possibilities for a new generation of radiation therapy equipment. Acta Oncol 1987, 26:403-412.
34. Brahme A, Eenmaa J, Lindback S, et al. Neutron beam characteristics from 50MeV photons on beryllium using a continuously variable multileaf collimator. Radiother Oncol 1983, 1:65-76.
35. Brahme A, Kraepelien T, Svensson H Electron and photon beams from a 50 MeV racetrack microtron. Acta Radiol Oncol 1980, 19:305-319.
36. Brahme A, Reisstad D Microtrons for electron and photon radiotherapy. IEEE Trans Nucl Sci NS-1981, 28:1880-1883.
37. Galvin JM, Smith AR, Lally B Characterization of a multileaf collimator system. Int J Radiat Oncol Biol Phys 1993, 25:181-192.
38. Jordan TJ, Williams PC The design and performance characteristics of a multileaf collimator. PMB 1994, 39:231-251.
39. Mohan R Field shaping for three-dimensional conformal radiation therapy and multileaf collimation. Semin Radiat Oncol 1995, 5:86-99.
40. Fraass BA, Marsh L, Martel MK, et al. Multileaf collimator-based intensity modulation for conformal therapy (abstract). Med Phys 1994, 21:1008.
41. Galvin JM, Chen X-G, Smith RM Combining multileaf fields to modulate fluence distributions. Int J Radiat Oncol Biol Phys 1993, 27:697-705.
42. Lane RG, Loyd MD, Chow CH, et al. Custom beam profiles in computer-controlled radiation therapy. Int J Radiat Oncol Biol Phys 1991, 22:167-174.
43. Zacarias AS, Lane RG, Rosen Assessment of a linear accelerator for segmented conformal radiation therapy. Med Phys 1993, 20:193-198.
44. De Neve W, De Gersem W, Derycke S, et al. Clinical delivery of intensity modulated conformal radiotherapy for relapsed or second-primary head and neck cancer using a multileaf collimator with dynamic control. Radiother Oncol 1999, 50:301-314.
45. Bortfeld TR, Kahler DL, Waldron TJ, Boyer AJ X-ray field compensation with multileaf collimators. Int J Radiat Oncol Biol Phys 1994, 28:723-730.
46. Kallman P, Lind B, Eklof A, Brahme A Shaping of arbitrary dose distributions by dynamic multileaf collimation. PMB 1988, 33:1291-1300.
47. Spirou SV, Chui CS Generation of arbitrary intensity profiles by dynamic jaws or multileaf collimators. Med Phys 1994, 21:1031-1041.
48. Brahme A Optimization of stationary and moving beam radiation therapy techniques. Radiother Oncol 1988, 12:129-140.
49. Holmes T, Mackie TR A filtered backprojection dose calculation method for inverse planning. Med Phys 1994, 21:303-313.
50. Mohan R, Mageras GS, Baldwin B, et al. Clinically relevant optimization of 3D conformal treatments. Med Phys 1992, 19:933-944.
51. Webb S Optimisation of conformal radiation therapy dose distributions by simulated annealing. Phys Med Biol 1989, 34:1349-1370.
52. Webb S Optimization by simulated annealing of three-dimensional treatment planning for radiation fields defined by a multileaf collimator. Phys Med Biol 1991, 36:1201-1226.
53. Boyer AL, Butler EB, DiPetrillo TA, et al. Intensity Modulated Radiation Therapy Collaborative Working Group. Intensity modulated radiotherapy. Current status and issues of interest. Int J Radiat Oncol Biol Phys 2001, 51:880-914.
54. Brahme A Optimization of conformation and general moving beam radiation therapy techniques. Use Comput Radiat Ther 1987, (9th ICCR):227-234.
55. Bortfeld T, Burkelbach J, Boesecke R, Schlegel W Methods of image reconstruction from projection applied to conformation radiotherapy. PMB 1990, 35:1423-1434.
56. Carol M Integrated 3D conformal multivane intensity modulation delivery system for radiotherapy. Proceedings of the XIth international conference on the use of computers in radiation therapy 1994, 172. Medical Physics, Manchester, UK. A. Hounsell, J. Wilkinson, P. Williams (Eds.).
57. Mackie TR, Holmes T, Swerdloff S, et al. A new concept for the delivery of dynamic conformal radiotherapy. Med Phys 1990, 20:1709-1719.
58. Yu CX Intensity-modulated arc therapy with dynamic multileaf collimation. An alternative to tomotherapy. Phys Med Biol 1995, 40:1435-1449.
59. Shepard DM, Cao D, Afghan MK, Earl MA An arc-sequencing algorithm for intensity modulated arc therapy. Med Phys 2007, 34:464-470.
60. Otto K Volumetric modulated arc therapy. IMRT in a single gantry arc. Med Phys 2008, 35:310-317.
61. Kessler ML, McShan DL, Epelman MA, et al. Costlets. A generalized approach to cost functions for automated optimization of IMRT treatment plans. Optim Eng 2005, 6:421-448.
62. Craft D, Halabi TF, Shih HA, Bortfeld TR Approximating convex Pareto surfaces in multiobjective radiotherapy planning. Med Phys 2006, 33:3399-3407.
63. Jee K, McShan DL, Fraass BA Preemptive lexicographic ordering. More intuitive IMRT optimization. Phys Med Bio 2007, 52:1845-1861.
64. Antonuk LE, Yorkston J, Boudry J, et al. Large area amorphous silicon photodiode arrays for radiotherapy and diagnostic imaging. Nucl Inst Meth 1991, A310:460-464.
65. Jaffray DA, Siewerdsen JH, Wong JW, Martinez AA Flat-panel cone-beam computed tomography for image-guided radiation therapy. Int J Radiat Oncol Biol Phys 2002, 53:1337-1349.
66. McLaughlin PW, Wygoda A, Sahijdak W, et al. The effect of patient position and treatment technique in conformal treatment of prostate cancer. Int J Radiat Oncol Biol Phys 1999, 45:407-413.
67. Bentel GC, Marks LB, Krishnamurthy R Impact of cradle immobilization on setup reproducibility during external beam radiation therapy for lung cancer. Int J Radiat Oncol Biol Phys 1997, 38:527-531.
68. Low DA, Nystrom M, Kalinin E, et al. A method for the reconstruction of four-dimensional synchronized CT scans acquired during free breathing. Med Phys 2003, 30:1254-1263.
69. Kubo HD, Hill BC Respiration gated radiotherapy treatment. A technical study. Phys Med Biol 1996, 41:83-91.
70. Wong JW, Sharpe MB, Jaffray DA, et al. The use of active breathing control (ABC) to reduce margin for breathing motion. Int J Radiat Oncol Biol Phys 1999, 44:911-919.
71. Dawson LA, Brock KK, Kazanjian S, et al. The reproducibility of organ position using active breathing control (ABC) during liver radiotherapy. Int J Radiat Oncol Biol Phys 2001, 51:1410-1421.
72. ICRU Report 50: prescribing, recording, and reporting photon beam therapy 1993, International Commission on Radiation Units and Measurements, Bethesda, MD.
73. van Herk M, Remeijer P, Rasch C, Lebesque JV The probability of correct target dosage: dose-population histograms for deriving treatment margins in radiotherapy. Int J Radiat Oncol Biol Phys 2000, 47:1121-1135.
74. Fraass BA, Kessler ML, McShan DL, et al. Optimization and clinical use of multisegment IMRT for high dose conformal therapy. Semin Radiat Oncol 1999, 9:60-77.
75. Shepard DM, Earl MA, Li XA, et al. Direct aperture optimization. A turnkey solution for step-and-shoot IMRT. Med Phys 2002, 29:1007-1018.
76. Fraass BA, Lash KL, Matrone GM, et al. The impact of treatment complexity and computer-control delivery technology on treatment delivery errors. Int J Radiat Oncol Biol Phys 1998, 42:651-659.
77. Fraass BA, McShan DL, Kessler ML Dose-based conformal field shaping using automated optimization. Proceedings of the XIIIth International Conference on the Use of Computers in Radiotherapy 2000, 32-35. Heidelberg, Germany. T. Bortfeld, W. Schlegel (Eds.).
78. Milan J, Bentley RE An interactive digital computer system for radiotherapy treatment planning. Br J Radiol 1974, 47:115-121.
79. Sterling TD, Perry H, Katz L Automation of radiation treatment planning. Br J Radiol 1964, 37:544-550.
80. van de Geijn J The computation of two and three dimensional dose distributions in cobalt-60 teletherapy. Br J Radiol 1965, 38:369-377.
81. van de Geijn J, Fraass BA Net fractional depth dose. A basis for a unified analytical description of FDD, TAR, TMR and TPR. Med Phys 1984, 11:784-793.
82. Cunningham JR, Shrivastava PN, Wilkinson JM Program IRREG. Calculation of dose from irregularly shaped radiation beams. Comput Prog Biomed 1972, 2:192-199.
83. Fraass BA, McShan DL, Ten Haken RK, Hutchins KM 3D treatment planning. V. A fast 3D photon calculation model. The use of computers in radiation therapy 1987, 521-525. Elsevier Science BV, North Holland. I.A.D. Bruinvis, F.H. van der Giessen, H.J. van Kleffens, F.W. Wittkamper (Eds.).
84. Mackie TR, Scrimger JW, Battista JJ A convolution method of calculation dose for 15-MV X-rays. Med Phys 1985, 12:188-196.
85. Ahnesjo A Collapsed cone convolution of radiant energy for photon dose calculation in heterogeneous media. Med Phys 1989, 16:577-592.
86. Rogers DWO, Bielajew AF Monte Carlo techniques of electron and photon transport of radiation dosimetry. The dosimetry of ionizing radiation 1985, vol 3. Academic Press, New York.
87. Andreo P Monte Carlo techniques in medical radiation physics. Phys Med Biol 1991, 26:861-920.
88. Fraass BA, Doppke KP, Hunt MA, et al. American Association of Physicists in Medicine Task Group 53. Quality assurance for clinical radiotherapy treatment planning. Med Phys 1998, 25:1773-1829.
89. Kessler ML, Ten Haken RK, Fraass BA, McShan DL Expanding the use and effectiveness of dose-volume histograms for 3D treatment planning. I. Integration of 3D dose-display. Int J Radiat Oncol Biol Phys 1994, 29:1125-1131.
90. Ten Haken RK, Martel MK, Kessler ML, et al. Use of Veff and iso-NTCP in the implementation of dose escalation protocols. Int J Radiat Oncol Biol Phys 1993, 27:689-695.
91. Lyman JT Complication probability as assessed from dose volume histograms. Radiat Res 1985, 104:5-13.
92. Lyman JT, Wolbarst AB Optimization of radiation therapy. III. A method of assessing complication probabilities from dose volume histograms. Int J Radiat Oncol Biol Phys 1987, 13:103-109.
93. Kutcher GJ, Burman C, Brewster L, et al. Histogram reduction method for calculating complication probabilities for 3D treatment planning evaluations. Int J Radiat Oncol Biol Phys 1991, 21:137-146.
94. Emami B, Lyman J, Brown A, et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 1991, 21:109-122.
95. Bentzen SM, Constine LS, Deasy JO, et al. Quantitative analyses of normal tissue effects in the clinic. Int J Radiat Oncol Biol Phys 2010, 76(Suppl):S3-S9.
96. Dawson LA, Normolle D, Balter JM, et al. Analysis of radiation induced liver disease using the Lyman NTCP model. Int J Radiat Oncol Biol Phys 2002, 53:810-821.
97. Hayman JA, Martel MK, Ten Haken RK, et al. Dose escalation in non-small-cell lung cancer using three-dimensional conformal radiation therapy. Update of a phase I trial. J Clin Oncol 2001, 19:127-136.
98. Niemierko A, Goitein M Implementation of a model for estimating tumor control probability for an inhomogeneously irradiated tumor. Radiother Oncol 1993, 29:140-147.
99. Webb S, Nahum AE A model for calculating tumour control probability including the effects of inhomogeneous distributions of dose and clonogenic cell density. Phys Med Biol 1993, 38:653-666.
100. Niemierko A Reporting and analyzing dose distributions. A concept of equivalent uniform dose. Med Phys 1997, 24:103-110.
101. Niemierko A A generalized concept of equivalent uniform dose. Med Phys 1999, 26:1100.
102. Wu Q, Mohan R, Niemierko A IMRT optimization based on the generalized equivalent uniform dose (EUD). Int J Radiat Oncol Biol Phys 2002, 52:224-235.
103. Vineberg KA, Eisbruch A, Kessler ML, et al. Is uniform target dose possible in IMRT plans for head and neck cancer?. Int J Radiat Oncol Biol Phys 2002, 52:1159-1172.
104. Kessler ML, McShan DL, Fraass BA A computer-controlled conformal radiotherapy system. III. Graphical simulation and monitoring of treatment delivery. Int J Radiat Oncol Biol Phys 1995, 33:1173-1180.
105. Siochi RA Minimizing static intensity modulation delivery time using an intensity solid paradigm. Int J Radiat Oncol Biol Phys 1999, 43:671-680.
106. van de Geijn J, Harrington FS, Fraass BA A graticule for evaluation of megavolt X ray port films. Int J Radiat Oncol Biol Phys 1982, 8:1999-2000.
107. Boyer AL, Antonuk LE, Fenster A, et al. A review of electronic portal imaging devices (EPIDs). Med Phys 1992, 19:1-16.
108. Antonuk LE, Boudry J, Huang W, et al. Demonstration of mega-voltage and diagnostic x-ray imaging with hydrogenated amorphous silicon arrays. Med Phys 1992, 19:1455-1466.
109. Balter JM, McShan DL, Lam KL, et al. Incorporation of patient setup measurement and adjustment within a computer controlled radiotherapy system. Proceedings of the XIIth International Conference on the Use of Computers in Radiation Therapy-ICCRT 1997, Advanced Medical, Madison, Wisconsin. G. Starkschall, D.D. Leavitt (Eds.).
110. Fraass BA, McShan DL, Kessler ML, et al. A computer-controlled conformal radiotherapy system. I. Overview. Int J Radiat Oncol Biol Phys 1995, 33:1139-1157.
111. McShan DL, Fraass BA, Kessler ML, et al. A computer-controlled conformal radiotherapy system. II. Sequence processor. Int J Radiat Oncol Biol Phys 1995, 33:1159-1172.
112. Fraass BA, McShan DL, Matrone GM, et al. A computer-controlled conformal radiotherapy system. IV. Electronic chart. Int J Radiat Oncol Biol Phys 1995, 33:1181-1194.
113. de Boer JC, Heijmen BJ, Pasma KL, Visser AG Characterization of a high-elbow, fluoroscopic electronic portal imaging device for portal dosimetry. Phys Med Biol 2000, 45:197-216.
114. Louwe RJW, McDermott LN, Sonke J-J, et al. The long-term stability of amorphous silicon flat panel imaging devices for dosimetry purposes. Med Phys 2004, 31:2989-2995.
115. Litzenberg DW, Moran JM, Fraass BA A semi-automated analysis tool for evaluation of dynamic MLC delivery. J Appl Clin Med Phys 2002, 3:63-72.
116. Balter JM, Brock KK, Litzenberg DW, et al. Daily targeting of intrahepatic tumors for radiotherapy. Int J Radiat Oncol Biol Phys 2002, 52:266-271.
117. Bel A, Vos PH, Rodrigus PTR, et al. High-precision prostate cancer irradiation by clinical application of an offline patient setup verification procedure, using portal imaging. Int J Radiat Oncol Biol Phys 1997, 35:321-332.
118. de Boer HC, Heijmen BJ A protocol for the reduction of systematic patient setup errors with minimal portal imaging workload. Int J Radiat Oncol Biol Phys 2001, 50:1350-1365.
119. Sonke JJ, Zijp L, Remeijer P, van Herk M Respiratory correlated cone-beam CT. Med Phys 2005, 32:1176-1186.
120. van Lin EN, van der Vight L, Huizenga H, et al. Set up improvement in head and neck radiotherapy using a 3D off-line EPID-based correction protocol and a customized head and neck support. Radiother Oncol 2003, 68:137-148.
121. De Boer JC, Heijman BJ A new approach to off-line setup corrections. Combining safety with minimal workload. Med Phys 2002, 29:1998-2012.
122. Balter JM, Brock KK, Litzenberg DW, et al. Daily targeting of intrahepatic tumors for radiotherapy. Int J Radiat Oncol Biol Phys 2002, 52:266-271.
123. Keall PJ, Joshi S, Vedam SS, et al. Four-dimensional radiotherapy planning for DMLC-based respiratory motion tracking. Med Phys 2005, 32:942-951.
124. Shirato H, Oita M, Fujita K, et al. Three dimensional conformal setup of patients using the coordinate system provided by three internal fiducial markers and two orthogonal diagnostic x-ray systems in the room. Int J Radiat Oncol Biol Phys 2004, 60:607-612.
125. Zelefsky MJ, Fuks Z, Hunt M, et al. High-dose intensity modulated radiation therapy for prostate cancer. Early toxicity and biochemical outcome in 772 patients. Int J Radiat Oncol Biol Phys 2002, 53:1111-1116.
126. Dawson LA, Litzenberg DW, Brock KK, et al. A comparison of ventilatory prostate movement in four treatment positions. Int J Radiat Oncol Biol Phys 2000, 48:319-323.
127. Kessler ML, Meyers C, Balter J, et al. A robust system for registration of 3D and 4D image data. Proceedings of the XIVth International Conference on Computers in Radiation Therapy 2004, 383-385. Jeong, South Korea. B.Y. Yi, S.D. Ahn, E.J. Choi, S.W. Ha (Eds.).
128. Logue JP, Sharrock CL, Cowan RA, et al. Clinical variability of target volume description in conformal radiotherapy planning. Int J Radiat Oncol Biol Phys 1998, 41:929-931.
129. Nowak P, van Dieren E, van Sornsen J, et al. Treatment portals for elective radiotherapy of the neck. An inventory in the Netherlands. Radiother Oncol 1997, 43:81-86.
130. Eisbruch A, Foote RL, O'Sullivan B, et al. IMRT for head and neck cancer. Emphasis on the selection and delineation of the targets. Semin Radiat Oncol 2002, 12:238-249.
131. Gregoire V, Coche E, Cosnard G, et al. Selection and delineation of lymph node target volumes in head and neck conformal radiotherapy. Proposal for standardizing terminology and procedure based on the surgical experience. Radiother Oncol 2000, 56:135-150.
132. Madu CN, Quint DJ, Normolle DP, et al. Definition of supraclavicular and infraclavicular nodes. Implications for three-dimensional CT-based conformal radiation therapy. Radiology 2001, 221:333-339.
133. Clinical target volumes in conformal and intensity modulated radiation therapy 2004, Springer-Verlag, Berlin. V. Gregoire, P. Scalliet, K.K. Ang (Eds.).
134. Chao KS, Ozygit G, Tran BN, et al. Pattern of failure in patients receiving definitive and postoperative IMRT for head and neck cancer. Int J Radiat Oncol Biol Phys 2003, 56:312-321.
135. Lee N, Xia P, Fischbain NJ, et al. Intensity-modulated radiation therapy for head and neck cancer. The UCSF experience focusing on target volume delineation. Int J Radiat Oncol Biol Phys 2003, 57:49-60.
136. Eisbruch A, Marsh LH, Dawson LA, et al. Recurrences near the base of skull following IMRT of head and neck cancer. Implications for target delineation in the high neck and for parotid gland sparing. Int J Radiat Oncol Biol Phys 2004, 59:28-42.
137. Som PM The present controversy over the imaging method of choice for evaluating the soft tissue of the neck. AJNR Am J Neuroradiol 1997, 18:1869-1872.
138. Daisne JF, Duprez T, Weynand B, et al. Tumor volume in pharyngolaryngeal squamous cell carcinoma. Comparison at CT, MR imaging, and FDG PET and validation with surgical specimen. Radiology 2004, 233:93-100.
139. Nishioka T, Shiga T, Shirato H, et al. Image fusion between 18FDG PET and MRI/CT for radiotherapy planning of oropharyngeal and nasopharyngeal carcinomas. Int J Radiat Oncol Biol Phys 2002, 53:1051-1057.
140. Schechter NR, Gillenwater AM, Byers RM, et al. Can positron emission tomography improve the quality of care for head and neck cancer patients?. Int J Radiat Oncol Biol Phys 2001, 51:4-9.
141. Stoeckli SJ, Steinert H, Pfaltz M, Schmidt S Is there a role for positron emission tomography with 18F-fluorodeoxyglucose in the initial staging of nodal negative oral and oropharyngeal squamous cell carcinoma. Head Neck 2002, 24:345-349.
142. Greven KM Positron emission tomography for head and neck cancer. Semin Radiat Oncol 2004, 14:121-129.
143. Gregoire V, Levendag P, Ang KK, et al. CT-based delineation of lymph node levels in the node negative neck. Consensus guidelines Available at. http://www.rtog.org/hnatlas/main.htm.
144. Nowak PJCM, Wijers OB, Lagerwaard FJ, Levendag PC A three-dimensional CT-based target definition for elective irradiation of the neck. Int J Radiat Oncol Biol Phys 1999, 45:33-39.
145. Wijers OB, Levendag PC, Tan T, et al. A simplified CT-based definition of the lymph node levels in the node negative neck. Radiother Oncol 1999, 52:35-42.
146. Chao KSC, Wippold FJ, Ozygit G, et al. Determination and delineation of nodal target volumes for head and neck cancer based on patterns of failure in patients receiving definitive and postoperative IMRT. Int J Radiat Oncol Biol Phys 2002, 53:1174-1184.
147. Lardinois D, Weder W, Hany TF, et al. Staging of non-small cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med 2003, 348:2500-2507.
148. Nestle U, Walter K, Schmidt S, et al. 18F-Deoxyglucose positron emission tomography for the planning of radiotherapy in lung cancer. High impact in patients with atelectasis. Int J Radiat Oncol Biol Phys 1999, 44:593-597.
149. Mah K, Caldwell CB, Ung YC, et al. The impact of 18FDG-PET on target and critical organs in CT-based treatment planning of patients with poorly defined non-small cell lung carcinoma. Prospective study. Int J Radiat Oncol Biol Phys 2002, 52:339-350.
150. Giraud P, Antoine M, Larrouy A, et al. Evaluation of microscopic tumor extent in non-small cell lung cancer for three-dimensional conformal radiotherapy planning. Int J Radiat Oncol Biol Phys 2000, 48:1015-1024.
151. Grills IS, Fitch DL, Goldstein NS, et al. Clininicopathologic analysis of microscopic tumor extension in lung adenocarcinoma. Defining clinical target volume for radiotherapy. Int J Radiat Oncol Biol Phys 2007, 69:334-341.
152. Chapet O, Kong FM, Quint L, et al. CT-based definition of thoracic lymph node station. An atlas from the University of Michigan. Int J Radiat Oncol Biol Phys 2005, 63:170-178.
153. Narayan S, Henning GT, Ten Haken RK, et al. Results following treatment to doses of 92.4 or 102.9 Gy on a phase I dose escalation study for non-small cell lung cancer. Lung Cancer 2004, 44:79-88.
154. Rosenzweig KE, Fox JL, Yorke E, Amols H, et al. Results of a phase I dose escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable non-small cell lung carcinoma. Cancer 2005, 103:2118-2127.
155. International Commission on Radiation Units and Measurements ICRU Report 62: Prescribing, recording and reporting photon beam therapy (Supplement to ICRU Report 50) 2009, The Commission, Bethesda, Maryland.
156. Stevens CW, Munden RE, Forster KM, et al. Respiratory driven lung tumor motion is independent of tumor size, tumor location and pulmonary function. Int J Radiat Oncol Biol Phys 2001, 51:62-68.
157. Husstedt HW, Sickert M, Kostler H, et al. Diagnostic value of fast-FLAIR sequence in MR imaging of intracranial tumors. Eur Radiol 2000, 10:745-752.
158. Chan JL, Lee SW, Fraass BA, et al. Survival and failure patterns of high grade gliomas after three-dimensional conformal radiotherapy. J Clin Oncol 2002, 20:1635-1642.
159. Ben Josef E, Shields AF, Vaishampayan U, et al. Intensity modulated radiotherapy and concurrent capecitabine for pancreatic cancer. Int J Radiat Oncol Biol Phys 2004, 59:454-459.
160. Bussels B, Goethals L, Feron M, et al. Respiration-induced movement of the upper abdominal organs. A pitfall for the three-dimensional conformal radiation treatment of pancreatic cancer. Radiother Oncol 2003, 68:69-74.
161. Myerson RJ, Garofalo MC, Naqa IE, et al. Elective clinical target volumes for conformal therapy in anorectal cancer. A Radiation Therapy Oncology Group Consensus Panel contouring atlas. Int J Radiat Oncol Biol Phys 2008, 74:824-830.
162. Kurhanewicz J, Vigneron DB, Hricak H, et al. Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high spatial resolution. Radiology 1996, 198:795-805.
163. Xia P, Pickett B, Vigneault E, et al. Forward or inversely planned segmental multileaf collimator IMRT and sequential tomotherapy to treat multiple dominant intraprostatic lesions of prostate cancer. Int J Radiat Oncol Biol Phys 2001, 51:244-254.
164. Zelefsky MJ, Fuks Z, Leibel SA Intensity modulated radiation therapy for prostate cancer. Semin Radiat Oncol 2002, 12:229-237.
165. Kumar R, Alavi A PET imaging in gynecologic malignancies. Radiol Clin North Am 2004, 42:1155-1167.
166. Lim K, Small W, Portelance L, et al. Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy for the definitive treatment of cervix cancer. Int J Radiat Oncol Biol Phys 2011, 79:348-355.
167. Chao KS, Lin M Lymphangiogram-assisted lymph node target delineation for patients with gynecologic malignancies. Int J Radiat Oncol Biol Phys 2002, 54:1147-1152.
168. Krueger EA, Fraass BA, McShan DL, et al. Potential gains for irradiation of chest wall and regional nodes with intensity modulated radiation therapy (IMRT). Int J Radiat Oncol Biol Phys 2003, 56:1023-1037.
169. Bentel G, Marks LB, Hardenbergh P, Prosnitz L Variability of the location of internal mammary vessels and glandular breast tissue in breast cancer patients undergoing routine CT-based treatment planning. Int J Radiat Oncol Biol Phys 1999, 44:1017-1025.
170. Krueger EA, Fraass BA, Pierce LJ Clinical aspects of intensity modulated radiotherapy in the treatment of breast cancer. Semin Radiat Oncol 2002, 12:250-259.
171. Jolly S, Kestin LL, Goldstein NS, Vicini FA pathologic anatomy of early stage breast cancer and its relevance to APBI. Defining the target. Accelerated partial breast irradiation: techniques and clinical implementation 2009, 35-45. Springer, New York. ed 2. D.E. Wazer, D.W. Arthur, F.A. Vicini (Eds.).
172. Vicini F, Winter K, Wong J, et al. Initial efficacy results of RTOG 0319. Three-dimensional conformal radiation therapy (3D-CRT) confined to the region of the lumpectomy cavity for stage I/II breast carcinoma. Int J Radiat Oncol Biol Phys 2010, 77:1120-1127.
173. Wu Q, Manning M, Schmidt-Ullrich R, Mohan R The potential for sparing of parotids and escalation of biologically equivalent dose with intensity modulated radiation treatments of head and neck cancers. A treatment design study. Int J Radiat Oncol Biol Phys 2000, 46:195-205.
174. Chao KSC, Bosch WR, Mutic S, et al. A novel approach to overcome hypoxic tumor resistance. Cu-ATSM guided intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys 2001, 49:1171-1182.
175. Eisbruch A, Ship JA, Martel MK, et al. Parotid gland sparing in patients undergoing bilateral head and neck irradiation. Techniques and early results. Int J Radiat Oncol Biol Phys 1996, 36:469-480.
176. Eisbruch A, Marsh LH, Martel MK, et al. Comprehensive irradiation of head and neck cancer using conformal multisegmental fields: assessment of target coverage and noninvolved tissue sparing. Int J Radiat Oncol Biol Phys 1998, 41:559-568.
177. Chao KS, Low D, Perez CA, Purdy JA Intensity-modulated radiation therapy in head and neck cancer. The Mallinckrodt experience. Int J Cancer 2000, 90:92-103.
178. Lee N, Xia P, Akazawa P, et al. Intensity modulated radiotherapy in the treatment of nasopharyngeal carcinoma. An update of the UCSF experience. Int J Radiat Oncol Biol 2002, 53:12-21.
179. Kam MK, Leung SF, Zee B, et al. Prospective randomized study of IMRT on salivary gland function in early stage nasopharyngeal cancer. J Clin Oncol 2007, 25:4873-4879.
180. Pow EH, Kwong DL, McMillan AS, et al. Xerostomia and quality of life after IMRT vs conventional radiotherapy for early stage nasopharyngeal cancer. Int J Radiat Oncol Biol Phys 2006, 66:981-991.
181. Nutting C, A'Hern R, Rogers MS, et al. First results of phase III multicenter randomized controlled study of IMRT versus conventional RT in head and neck cancer. J Clin Oncol 2009, 27(Suppl: Abstract LBA6006):18s.
182. Murdoch-Kinch CA, Kim HM, Vineberg KA, et al. Dose-effect relationships for the submandibular salivary glands and implications for their sparing by IMRT. Int J Radiat Oncol Biol Phys 2008, 72:373-382.
183. Eisbruch A, Kim HM, Terrell JE, et al. Xerostomia and its predictors following parotid-sparing irradiation of head and neck cancer. Int J Radiat Oncol Biol Phys 2001, 50:695-704.
184. Tsien C, Eisbruch A, McShan D, et al. IMRT for locally advanced paranasal sinus tumors. Incorporating clinical decisions in the automated optimization process. Int J Radiat Oncol Biol Phys 2003, 55:776-784.
185. Pan CC, Eisbruch A, Lee SJ, et al. Prospective study of dose and inner ear function relationships in irradiated head and neck cancer patients. Int J Radiat Oncol Biol Phys 2005, 61:1393-1402.
186. Lee N, Chuang C, Quivey IM, et al. Skin toxicity due to intensity modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 2002, 53:630-637.
187. Rosenthal DI, Fuller CD, Ang KK, et al. Pre-and postinduction chemotherapy target volume delineation in head and neck cancer. Preliminary results from an expert panel. Int J Radiat Oncol Biol Phys 2010, 75(Suppl):S431.
188. Eisbruch A, Schwartz M, Rasch C, et al. Dysphagia and aspiration following chemo-irradiation of head and neck cancer. Which anatomical structures are affected, and can they be spared by IMRT?. Int J Radiat Oncol Biol Phys 2004, 60:1425-1439.
189. Kong FM, Ten Haken R, Eisbruch A, Lawrence T Non-small cell lung cancer therapy-related pulmonary toxicity. An update on radiation pneumonitis and fibrosis. Semin Oncol 2005, 32(Suppl 3):S42-S54.
190. Shi A, Zhu G, Wu H, et al. Analysis of clinical and dosimetric factors associated with severe acute radiation pneumonitis in patients with locally advanced non-small cell lung cancer treated with concurrent chemotherapy and intensity-modulated radiotherapy. Radiat Oncol 2010, 12:35.
191. Munawar I, Yaremko BP, Craig J, et al. Intensity modulated radiotherapy of non-small-cell lung cancer incorporating SPECT ventilation imaging. Med Phys 2010, 37:1863-1872.
192. Wang I, Yorke E, Desobry G, et al. Dosimetric advantage of using 6 MV over 15 MV photons in conformal therapy of lung cancer. Monte Carlo studies in patient geometries. J Appl Clin Med Phys 2002, 3:51-59.
193. Kestin LL, Sharpe MB, Frazier RC, et al. Intensity modulation to improve dose uniformity with tangential breast radiotherapy. Initial clinical experience. Int J Radiat Oncol Biol Phys 2000, 48:1559-1568.
194. Baglan KL, Sharpe MB, Jaffray D, et al. Accelerated partial breast irradiation using 3D conformal radiation therapy (3D-CRT). Int J Radiat Oncol Biol Phys 2003, 55:302-311.
195. Zelefsky MJ, Fuks Z, Hunt M, et al. High dose radiation delivered by IMRT improves the outcome of localized prostate cancer. J Urol 2001, 166:876-881.
196. Symon Z, Griffith KA, McLaughlin PW, et al. Dose escalation for localized prostate cancer: substantial benefit observed with 3D conformal therapy. Int J Radiat Oncol Biol Phys 2003, 57:384-390.
197. Pollack A, Hanlon AL, Horwitz EM, et al. Prostate cancer radiotherapy dose response. An update of the Fox Chase experience. J Urol 2004, 171:1132-1136.
198. Kao J, Turian J, Hamilton RJ, et al. Sparing of the penile bulb and proximal penile structures with intensity modulated radiation therapy for prostate cancer. Br J Radiol 2004, 77:129-136.
199. McLaughlin PW, Narayana V, Meirovitz A, et al. Vessel-sparing prostate radiotherapy. Dose limitation to critical erectile vascular structures defined by MRI. Int J Radiat Oncol Biol Phys 2005, 61:20-31.
200. Desai S, Ben-Josef E, Griffith KA, et al. Gemcitabine-based combination chemotherapy followed by radiation with capecitabine as adjuvant therapy for resected pancreas cancer. Int J Radiat Oncol Biol Phys 2009, 75:1450-1455.
201. Roeske JC, Lujan A, Rotmensch J, et al. Intensity modulated whole pelvis radiation therapy in patients with gynecologic malignancies. Int J Radiat Oncol Biol Phys 2000, 48:1613-1621.
202. Mundt AJ, Roeske JC Could intensity modulated radiation therapy replace brachytherapy in the treatment of cervical cancer?. Brachytherapy J 2002, 1:195-196.
203. Mell LK, Tiryaki H, Ahn KH, et al. Dosimetric comparison of bone marrow-sparing intensity-modulated radiotherapy versus conventional techniques for treatment of cervical cancer. Int J Radiat Oncol Biol Phys 2008, 71:1504-1510.
204. Lujan AE, Mundt AJ, Yamada SD, et al. Intensity modulated radiotherapy as a means to reducing dose to bone marrow in gynecologic patients receiving whole pelvic radiotherapy. Int J Radiat Oncol Biol Phys 2003, 57:516-521.
205. Huang E, Teh BS, Strother DR, et al. Intensity modulated radiotherapy for pediatric medulloblastoma. Early report on the reduction of ototoxicity. Int J Radiat Oncol Biol Phys 2003, 52:599-605.
206. Fukunaga-Johnson N, Sandler HM, Marsh R, et al. The use of 3D conformal radiotherapy to spare the cochlea in patients with medulloblastoma. Int J Radiat Oncol Biol Phys 1998, 41:77-82.
207. Mohan R, Wu Q, Manning M, Schmidt-Ullrich R Radiobiological considerations in the design of fractionation strategies for intensity modulated radiation therapy of the head and neck. Int J Radiat Oncol Biol Phys 2000, 46:619-630.
208. Wu Q, Manning M, Schmidt-Ullrich R, Mohan R The potential for sparing of parotids and escalation of biologically equivalent dose with intensity modulated radiation treatments of head and neck cancers. A treatment design study. Int J Radiat Oncol Biol Phys 2000, 46:195-205.
209. Lu Tx, Mai WY, The BS, et al. Initial experience using intensity modulated radiotherapy for recurrent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2004, 58:682-687.
210. Mohan R, Zhang X, Wang H, et al. Use of deformed intensity distributions for on-line modification of image-guided IMRT to account for interfractional anatomic changes. Int J Radiat Oncol Biol Phys 2005, 61:1258-1266.
211. Barker JL, Garden AS, Ang K, et al. Quantification of volumetric and geometric changes occurring during fractionated radiotherapy for head and neck cancer using an integrated CT/linear accelerator system. Int J Radiat Oncol Biol Phys 2004, 59:960-970.
212. Ling CC, Humm J, Larson S, et al. Toward multidimensional radiotherapy. Biological imaging and biological conformality. Int J Radiat Oncol Biol Phys 2000, 47:551-560.
213. Hockel M, Schlenger K, Mitze M, et al. Hypoxia and radiation response in human tumors. Semin Radiat Oncol 1996, 6:3-9.
214. Lindsay KA, Wheldon EG, Deehan C, et al. Radiation carcinogenesis modeling for risk of treatment-related second tumors following radiotherapy. Br J Radiol 2001, 74:529-536.
215. Fowler JF, Welsh JS, Howard SP Loss of biological effect in prolonged fraction delivery. Int J Radiat Oncol Biol Phys 2004, 59:242-249.
216. Lee N, Harris J, Garden AS, et al. IMRT with or without chemotherapy for nasopharyngeal cancer. RTOG 0225. J Clin Oncol 2009, 27:3684-3690.
217. Eisbruch A, Harris J, Garden AS, et al. Accelerated hypofractionated IMRT for early stage oropharyngeal cancer. Int J Radiat Oncol Biol Phys 2010, 76:1333-1338.
218. Kam MK, Leung SF, Zee B, et al. Impact of intensity modulated radiotherapy on salivary gland function in early stage nasopharyngeal carcinoma. A prospective randomized study. J Clin Oncol 2005, 23(Suppl 16):500s.
219. Butler EB, The BS, Grant WH, et al. SMART (simultaneous modulated accelerated radiation therapy) boost. A new accelerated fractionation schedule for the treatment of head and neck cancer with intensity modulated radiotherapy. Int J Radiat Oncol Biol Phys 1999, 45:21-32.
220. Amosson CM, Teh AK, Garg WY, et al. Accelerated fractionation for head and neck cancer using the SMART boost technique. Int J Radiat Oncol Biol Phys 2003, 57(2 Suppl):S306.
221. Lauve A, Morris M, Schmidt-Ullrich R, et al. Simultaneous integrated boost intensity modulated radiotherapy for locally advanced head and neck squamous cell carcinomas. II. Clinical results. Int J Radiat Oncol Biol Phys 2004, 60:374-387.
222. Chao KSC, Deasy JO, Markman J, et al. A prospective study of salivary function sparing in patients with head and neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results. Int J Radiat Oncol Biol Phys 2001, 49:907-916.
223. Sultanem K, Shu HK, Xia P, et al. Three-dimensional intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma. The University of California-San Francisco experience. Int J Radiat Oncol Biol Phys 2000, 48:711-722.
224. Lin A, Kim HM, Terrell JE, et al. Quality of life following parotid-sparing IMRT of head and neck cancer. A prospective longitudinal study. Int J Radiat Oncol Biol Phys 2003, 57:61-70.
225. Parliament MB, Scrimger R, Anderson SG, et al. Preservation of oral health-related quality of life and salivary flow rates after inverse-planned intensity-modulated radiotherapy (IMRT) for head and neck cancer. Int J Radiat Oncol Biol Phys 2004, 58:663-673.
226. Feng FY, Kim HM, Lyden TH, et al. intensity modulated chemoradiotherapy aiming to reduce dysphagia in patients with oropharyngeal cancer. Clinical and functional results. J Clin Oncol 2010, 28:2732-2738.
227. Eisbruch A, Kim HM, Ten Haken R, et al. Dose, volume and function relationships in parotid glands following conformal and intensity modulated irradiation of head and neck cancer. Int J Radiat Oncol Biol Phys 1999, 45:577-587.
228. Chao KSC, Deasy JO, Markman J, et al. A prospective study of salivary function sparing in patients with head and neck cancers receiving intensity-modulated or three-dimensional radiation therapy. Initial results. Int J Radiat Oncol Biol Phys 2001, 51:938-946.
229. Roesink JM, Moerland MA, Battersmann JJ, et al. Quantitative dose-volume response analysis of changes in parotid gland function after radiotherapy in the head and neck region. Int J Radiat Oncol Biol Phys 2001, 51:938-946.
230. Eisbruch A, Rhodus N, Rosenthal D, et al. How should we measure and report xerostomia?. Semin Radiat Oncol 2003, 13:226-234.
231. Vergeer MR, Doornaert PA, Rietveld DH, et al. IMRT reduces radiation-induced morbidity. Int J Radiat Oncol Biol Phys 2009, 74:1-8.
232. Kupelian PA, Reddy CA, Carlson TP, et al. Dose/volume relationships of late rectal bleeding after external beam radiotherapy for localized prostate cancer. Absolute or relative rectal volume?. Cancer J 2002, 8:62-66.
233. Huang EH, Pollack A, Levy L, et al. Late rectal toxicity. Dose-volume effects of conformal radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 2002, 54:1314-1321.
234. Skwarchuk MW, Jackson A, Zelefsky MJ, et al. Late rectal toxicity after conformal radiotherapy of prostate cancer. Multivariate analysis of dose-response. Int J Radiat Oncol Biol Phys 2000, 47:103-113.
235. Kupelian PA, Reddy CA, Klein EA, et al. Short course intensity modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer. Preliminary results on late toxicity and quality of life. Int J Radiat Oncol Biol Phys 2001, 51:988-993.
236. De Meerleer G, Fonteyne V, Meersschout S, et al. Salvage intensity-modulated radiotherapy for rising PSA after radical prostatectomy. Radiother Oncol 2008, 89:205-213.
237. Alongi F, Fiorino C, Cozzarini C, et al. IMRT significantly reduces acute toxicity of whole-pelvis irradiation in patients treated with post-operative adjuvant or salvage radiotherapy after radical prostatectomy. Radiother Oncol 2009, 93:207-212.
238. Rosenzweig KE, Mychalczak B, Fuks Z, et al. Final report of the 70.2 Gy and 75.6 Gy dose levels of a phase I dose escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable non-small cell lung cancer. Cancer 2000, 6:82-87.
239. Wu KL, Liao Y, Qian H, et al. Three-dimensional conformal radiation therapy for non-small cell lung cancer. A phase I/II dose escalation clinical trial. Int J Radiat Oncol Biol Phys 2003, 57:1336-1344.
240. Hayman J, Martel MK, Ten Haken RK, et al. Dose escalation in non-small-cell lung cancer using three-dimensional conformal radiation therapy. Update of a phase I trial. J Clin Oncol 2001, 19:127-136.
241. Belderbos JS, De Jaeger K, Heemsbergen WD, et al. First results of a phase I/II dose escalation trial in non-small cell lung cancer using three dimensional conformal radiotherapy. Radiother Oncol 2003, 66:119-126.
242. Singh AK, Lockett MA, Bradley JD Predictors of radiation-induced esophageal toxicity in patients with non-small cell lung cancer treated with three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 2000, 55:337-341.
243. Shi A, Zhu G, Wu H, et al. Analysis of clinical and dosimetric factors associated with severe acute radiation pneumonitis in patients with locally advanced non-small cell lung cancer treated with concurrent chemotherapy and intensity-modulated radiotherapy. Radiat Oncol 2010, 12:35.
244. Vicini FA, Sharpe M, Kestin L, et al. Optimizing breast cancer treatment efficacy with intensity modulated radiotherapy. Int J Radiat Oncol Biol Phys 2002, 54:1336-1344.
245. Hong L, Hunt M, Chui C, et al. Intensity-modulated tangential beam irradiation of the intact breast. Int J Radiat Oncol Biol Phys 1999, 44:1155-1164.
246. Pignol JP, Olivotto I, Rakovitch E, et al. A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis. J Clin Oncol 2008, 26:2085-2092.
247. Jagsi R, Ben-David MA, Moran JM, et al. Unacceptable cosmesis in a protocol investigating intensity-modulated radiotherapy with active breathing control for accelerated partial-breast irradiation. Int J Radiat Oncol Biol Phys 2010, 76:71-78.
248. Knab B, Mehta N, Roeske JC, et al. Outcome of endometrial cancer patients treated with adjuvant intensity modulated pelvic radiation therapy. Int J Radiat Oncol Biol Phys 2004, 60(Suppl 1):S303-S304.
249. Salama JK, Mundt AJ, Roeske J, Mehta N Preliminary outcome and toxicity report of extended-field, intensity-modulated radiation therapy for gynecologic malignancies. Int J Radiat Oncol Biol Phys 2006, 65:1170-1176.
250. Mundt AJ, Lujan AE, Rotmensch J, et al. Intensity-modulated whole pelvic radiotherapy in women with gynecologic malignancies. Int J Radiat Oncol Biol Phys 2002, 52:1330-1337.
251. Mundt AJ, Mell LK, Roeske JC, et al. Preliminary analysis of chronic gastrointestinal toxicity in gynecologic patients treated with intensity modulated whole pelvic radiation therapy. Int J Radiat Oncol Biol Phys 2003, 56:1354-1360.
252. Roeske JC, Lujan AE, Reba RC, et al. Incorporation of SPECT bone marrow imaging into intensity modulated whole-pelvic radiation therapy treatment planning for gynecologic malignancies. Radiother Oncol 2005, 77:11-17.
253. Takahashi S Conformation radiotherapy. Rotation techniques as applied to radiography and radiotherapy of cancer. Acta Radiol Suppl 1965, 242:1-141.
254. Levene MB, Kijewski PK, Chin LM, et al. Computer-controlled radiation therapy. Radiology 1978, 129:769-775.
255. Computed tomography in radiation therapy 1983, Raven Press, New York. C.C. Ling, C.C. Rogers, R.J. Morton (Eds.).
256. McShan DL, Fraass BA, Lichter AS Full integration of the beam's eye view concept into clinical treatment planning. Int J Radiat Oncol Biol Phys 1990, 18:1485-1494.
257. Fraass BA, McShan DL 3D treatment planning. I. Overview of a clinical planning system. The use of computers in radiation therapy 1987, 273-276. Elsevier Science BV, North Holland. I.A.D. Bruinvis, F.H. van der Giessen, H.J. van Kleffens, F.W. Wittkamper (Eds.).
258. Brahme A Design principles and clinical possibilities for a new generation of radiation therapy equipment. Acta Oncol 1987, 26:403-412.
259. De Neve W, De Gersem W, Derycke S, et al. Clinical delivery of intensity modulated conformal radiotherapy for relapsed or second-primary head and neck cancer using a multileaf collimator with dynamic control. Radiother Oncol 1999, 50:301-314.
260. Spirou SV, Chui CS Generation of arbitrary intensity profiles by dynamic jaws or multileaf collimators. Med Phys 1994, 21:1031-1041.
261. Brahme A Optimization of stationary and moving beam radiation therapy techniques. Radiother Oncol 1988, 12:129-140.
262. Webb S Optimization by simulated annealing of three-dimensional treatment planning for radiation fields defined by a multileaf collimator. Phys Med Biol 1991, 36:1201-1226.
263. Boyer AL, Butler EB, DiPetrillo TA, et al. Intensity Modulated Radiation Therapy Collaborative Working Group. Intensity modulated radiotherapy. Current status and issues of interest. Int J Radiat Oncol Biol Phys 2001, 51:880-914.
264. Bortfeld T, Burkelbach J, Boesecke R, Schlegel W Methods of image reconstruction from projection applied to conformation radiotherapy. PMB 1990, 35:1423-1434.
265. Antonuk LE, Yorkston J, Boudry J, et al. Large area amorphous silicon photodiode arrays for radiotherapy and diagnostic imaging. Nucl Inst Meth 1991, A310:460-464.
266. Jaffray DA, Siewerdsen JH, Wong JW, Martinez AA Flat-panel cone-beam computed tomography for image-guided radiation therapy. Int J Radiat Oncol Biol Phys 2002, 53:1337-1349.
267. ICRU Report 50: Prescribing, Recording, and Reporting Photon Beam Therapy 1993, International Commission on Radiation Units and Measurements, Bethesda, MD.
268. Fraass BA, Doppke KP, Hunt MA, et al. American Association of Physicists in Medicine Task Group 53. Quality assurance for clinical radiotherapy treatment planning. Med Phys 1998, 25:1773-1829.
269. Lyman JT Complication probability as assessed from dose volume histograms. Radiat Res 1985, 104:5-13.
270. Bentzen SM, Constine LS, Deasy JO, et al. Quantitative analyses of normal tissue effects in the clinic. Int J Radiat Oncol Biol Phys 2010, 76(Suppl):S3-S9.
271. Niemierko A A generalized concept of equivalent uniform dose. Med Phys 1999, 26:1100.
272. Zelefsky MJ, Fuks Z, Hunt M, et al. High-dose intensity modulated radiation therapy for prostate cancer. Early toxicity and biochemical outcome in 772 patients. Int J Radiat Oncol Biol Phys 2002, 53:1111-1116.
273. Clinical target volumes in conformal and intensity modulated radiation therapy 2004, Springer-Verlag, Berlin. V. Gregoire, P. Scalliet, K.K. Ang (Eds.).
274. Eisbruch A, Marsh LH, Dawson LA, et al. Recurrences near the base of skull following IMRT of head and neck cancer. Implications for target delineation in the high neck and for parotid gland sparing. Int J Radiat Oncol Biol Phys 2004, 59:28-42.
275. Gregoire V, Levendag P, Ang KK, et al. CT-based delineation of lymph node levels in the node negative neck. Consensus guidelines. Radiother Oncol 2003, 69(3):227-236. Available at. http://www.rtog.org/hnatlas/main.htm.
276. Narayan S, Henning GT, Ten Haken RK, et al. Results following treatment to doses of 92.4 or 102.9 Gy on a phase I dose escalation study for non-small cell lung cancer. Lung Cancer 2004, 44:79-88.
277. Rosenzweig KE, Fox JL, Yorke E, Amols H, et al. Results of a phase I dose escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable non-small cell lung carcinoma. Cancer 2005, 103:2118-2127.
278. International Commission on Radiation Units and Measurements ICRU Report 62: Prescribing, recording and reporting photon beam therapy (Supplement to ICRU Report 50) 2009, The Commission, Bethesda, Maryland.
279. Lim K, Small W, Portelance L, et al. Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy for the definitive treatment of cervix cancer. Int J Radiat Oncol Biol Phys 2011, 79:348-355.
280. Krueger EA, Fraass BA, Pierce LJ Clinical aspects of intensity modulated radiotherapy in the treatment of breast cancer. Semin Radiat Oncol 2002, 12:250-259.
281. Jolly S, Kestin LL, Goldstein NS, Vicini FA pathologic anatomy of early stage breast cancer and its relevance to APBI. Defining the target. Accelerated partial breast irradiation: techniques and clinical implementation 2009, 35-45. Springer, New York. ed 2. D.E. Wazer, D.W. Arthur, F.A. Vicini (Eds.).
282. Vicini F, Winter K, Wong J, et al. Initial efficacy results of RTOG 0319. Three-dimensional conformal radiation therapy (3D-CRT) confined to the region of the lumpectomy cavity for stage I/II breast carcinoma. Int J Radiat Oncol Biol Phys 2010, 77:1120-1127.
283. Eisbruch A, Marsh LH, Martel MK, et al. Comprehensive irradiation of head and neck cancer using conformal multisegmental fields: assessment of target coverage and noninvolved tissue sparing. Int J Radiat Oncol Biol Phys 1998, 41:559-568.
284. Chao KS, Low D, Perez CA, Purdy JA Intensity-modulated radiation therapy in head and neck cancer. The Mallinckrodt experience. Int J Cancer 2000, 90:92-103.
285. Lee N, Xia P, Akazawa P, et al. Intensity modulated radiotherapy in the treatment of nasopharyngeal carcinoma. An update of the UCSF experience. Int J Radiat Oncol Biol 2002, 53:12-21.
286. Kam MK, Leung SF, Zee B, et al. Prospective randomized study of IMRT on salivary gland function in early stage nasopharyngeal cancer. J Clin Oncol 2007, 25:4873-4879.
287. Pow EH, Kwong DL, McMillan AS, et al. Xerostomia and quality of life after IMRT vs conventional radiotherapy for early stage nasopharyngeal cancer. Int J Radiat Oncol Biol Phys 2006, 66:981-991.
288. Eisbruch A, Schwartz M, Rasch C, et al. Dysphagia and aspiration following chemo-irradiation of head and neck cancer. Which anatomical structures are affected, and can they be spared by IMRT?. Int J Radiat Oncol Biol Phys 2004, 60:1425-1439.
289. Kong FM, Ten Haken R, Eisbruch A, Lawrence T Non-small cell lung cancer therapy-related pulmonary toxicity. An update on radiation pneumonitis and fibrosis. Semin Oncol 2005, 32(Suppl 3):S42-S54.
290. Baglan KL, Sharpe MB, Jaffray D, et al. Accelerated partial breast irradiation using 3D conformal radiation therapy (3D-CRT). Int J Radiat Oncol Biol Phys 2003, 55:302-311.
291. Zelefsky MJ, Fuks Z, Hunt M, et al. High dose radiation delivered by IMRT improves the outcome of localized prostate cancer. J Urol 2001, 166:876-881.
292. Roeske JC, Lujan A, Rotmensch J, et al. Intensity modulated whole pelvis radiation therapy in patients with gynecologic malignancies. Int J Radiat Oncol Biol Phys 2000, 48:1613-1621.
293. Mohan R, Wu Q, Manning M, Schmidt-Ullrich R Radiobiological considerations in the design of fractionation strategies for intensity modulated radiation therapy of the head and neck. Int J Radiat Oncol Biol Phys 2000, 46:619-630.
294. Ling CC, Humm J, Larson S, et al. Toward multidimensional radiotherapy. Biological imaging and biological conformality. Int J Radiat Oncol Biol Phys 2000, 47:551-560.
295. Lee N, Harris J, Garden AS, et al. IMRT with or without chemotherapy for nasopharyngeal cancer. RTOG 0225. J Clin Oncol 2009, 27:3684-3690.
296. Eisbruch A, Harris J, Garden AS, et al. Accelerated hypofractionated IMRT for early stage oropharyngeal cancer. Int J Radiat Oncol Biol Phys 2010, 76:1333-1338.
297. Feng FY, Kim HM, Lyden TH, et al. intensity modulated chemoradiotherapy aiming to reduce dysphagia in patients with oropharyngeal cancer. Clinical and functional results. J Clin Oncol 2010, 28:2732-2738.
298. Eisbruch A, Rhodus N, Rosenthal D, et al. How should we measure and report xerostomia?. Semin Radiat Oncol 2003, 13:226-234.
299. Kupelian PA, Reddy CA, Klein EA, et al. Short course intensity modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer. Preliminary results on late toxicity and quality of life. Int J Radiat Oncol Biol Phys 2001, 51:988-993.
300. Hayman J, Martel MK, Ten Haken RK, et al. Dose escalation in non-small-cell lung cancer using three-dimensional conformal radiation therapy. Update of a phase I trial. J Clin Oncol 2001, 19:127-136.
301. Vicini FA, Sharpe M, Kestin L, et al. Optimizing breast cancer treatment efficacy with intensity modulated radiotherapy. Int J Radiat Oncol Biol Phys 2002, 54:1336-1344.
302. Pignol JP, Olivotto I, Rakovitch E, et al. A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis. J Clin Oncol 2008, 26:2085-2092.
303. Mundt AJ, Lujan AE, Rotmensch J, et al. Intensity-modulated whole pelvic radiotherapy in women with gynecologic malignancies. Int J Radiat Oncol Biol Phys 2002, 52:1330-1337.